Bulut, I. Et Al. 2018. Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab. JOURNAL OF ASTHMA , vol.55, no.10 , 1116-1121.

Bulut, I., Ozseker, Z. F., COSKUN, A., SERTESER, M., & Unsal, I., (2018). Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab. JOURNAL OF ASTHMA , vol.55, no.10, 1116-1121.

Bulut, Ismet Et Al. "Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab," JOURNAL OF ASTHMA , vol.55, no.10, 1116-1121, 2018

Bulut, Ismet Et Al. "Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab." JOURNAL OF ASTHMA , vol.55, no.10, pp.1116-1121, 2018

Bulut, I. Et Al. (2018) . "Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab." JOURNAL OF ASTHMA , vol.55, no.10, pp.1116-1121.

@article{article, author={Ismet Bulut Et Al. }, title={Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab}, journal={JOURNAL OF ASTHMA}, year=2018, pages={1116-1121} }